Mri Contrast Agents
Mri Contrast Agents - Related Videos
11:27
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
0 Views •
Cited by 5 •
2016
This protocol describes the preparation and characterization of a dendrimeric magnetic resonance imaging (MRI) contrast agent that carries cyclen-based macrocyclic chelates coordinating paramagnetic gadolinium ions. In a series of MRI experiments in vitro, this agent produced an amplified MRI signal when compared to the commercially available monomeric analogue.
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
0 Views •
Cited by 3 •
2013
To demonstrate MR cancer molecular imaging with a small peptide targeted MRI contrast agent specific to clotted plasma proteins in tumor stroma in a mouse prostate cancer model.
07:15
In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
0 Views •
Cited by 2 •
2013
We demonstrate how to perform macrophage MR imaging using ultrasmall superparamagnetic contrast agent (USPIO) in septic arthritis, allowing an initial and longitudinal in vivo non-invasive evaluation of macrophages infiltration and an assessment of therapy efficacy.
11:38
In vivo Imaging of Optic Nerve Fiber Integrity by Contrast-Enhanced MRI in Mice
0 Views •
Cited by 7 •
2014
This video illustrates a method, using a clinical 3 T scanner, for contrast-enhanced MR imaging of the naïve mouse visual projection and for repetitive and longitudinal in vivo studies of optic nerve degeneration associated with acute optic nerve crush injury and chronic optic nerve degeneration in knock-out mice (p50KO).
13:21
Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
0 Views •
Cited by 9 •
2011
We demonstrate the metalation, purification, and characterization of lanthanide complexes. The complexes described here can be conjugated to macromolecules to enable tracking of these molecules using magnetic resonance imaging.
FAQs
These agents can enhance images through different relaxation pathways. Paramagnetic gadolinium primarily alters T1 relaxation of nearby water protons, increasing signal intensity on selected sequences. Other agents produce magnetic susceptibility effects that influence T2 or T2* relaxation. The relevant pathway determines which MRI sequence best reveals the resulting contrast, so mechanism and acquisition must be considered together.
Gadolinium provides the paramagnetic property responsible for a major contrast mechanism. Its interaction with nearby water protons changes their T1 relaxation behavior, which can increase signal intensity on appropriately selected MRI sequences. This effect helps make differences between tissues, lesions, or vascular regions more conspicuous, but the imaging result depends on matching the agent’s behavior with the sequence used.
Selection affects whether the intended tissue, vascular, or functional feature becomes visible, because agents can act through different relaxation effects. Safety assessment is equally important before administration. Considering both factors supports reliable image interpretation and helps researchers use contrast enhancement appropriately when examining anatomy, permeability, inflammation, tumors, blood flow, or organ function.
A useful plan begins by identifying the biological target and the information sought, such as structural distinction, blood-flow assessment, permeability, inflammation, tumor visualization, or organ function. Researchers can then consider which relaxation effect and MRI sequence will provide the needed visibility, while incorporating agent selection and safety assessment. This planning improves the relevance and reliability of the resulting images.
By making vascular and tissue differences more visible, these agents support assessment of blood flow and tissue permeability. Enhancement patterns can therefore contribute to studies of how contrast reaches or distributes within biological structures. In biomedical research, this information helps connect MRI findings with dynamic physiological processes rather than anatomy alone.
It can support studies that compare normal and abnormal anatomy, investigate inflammation or tumors, evaluate organ function, and examine blood flow or tissue permeability. Because enhancement can reveal more than static structure, the method is useful for connecting image findings with physiological behavior. Agent choice and safety assessment remain necessary for interpreting these applications responsibly.